Steady State Bioequivalence of Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine in HIV-Infected Ugandan Adults

BACKGROUND: Generic antiretroviral therapy is the mainstay of HIV treatment in resource-limited settings, yet there is little evidence confirming the bioequivalence of generic and brand name formulations. We compared the steady-state pharmacokinetics of lamivudine, stavudine and nevirapine in HIV-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Byakika-Tusiime, Jayne, Chinn, Leslie W., Oyugi, Jessica H., Obua, Celestino, Bangsberg, David R., Kroetz, Deanna L.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602850/
https://www.ncbi.nlm.nih.gov/pubmed/19096711
http://dx.doi.org/10.1371/journal.pone.0003981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602850/
https://www.ncbi.nlm.nih.gov/pubmed/19096711
http://dx.doi.org/10.1371/journal.pone.0003981

Ejemplares similares